David Kroin - Net Worth and Insider Trading

David Kroin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Kroin owns 5 companies in total, including Foamix Pharmaceuticals Ltd (FOMX) , Adamas Pharmaceuticals Inc (ADMS) , and Connecture Inc (CNXR) among others .

Click here to see the complete history of David Kroin’s form 4 insider trades.

Insider Ownership Summary of David Kroin

Ticker	Comapny	Transaction Date	Type of Owner
FOMX	Foamix Pharmaceuticals Ltd	2018-09-13	other: Former 10% Owner
ADMS	Adamas Pharmaceuticals Inc	2017-06-19	10 percent owner
CNXR	Connecture Inc	2015-06-30	10 percent owner
INFU	InfuSystems Holdings Inc	2007-10-15	10 percent owner
ALBO	Albireo Pharma Inc	2007-05-10	director

David Kroin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David Kroin Ownership Network

Ownership Network List of David Kroin

No Data

Ownership Network Relation of David Kroin

David Kroin Owned Company Details

What does Foamix Pharmaceuticals Ltd do?

Who are the key executives at Foamix Pharmaceuticals Ltd?

David Kroin is the other: Former 10% Owner of Foamix Pharmaceuticals Ltd. Other key executives at Foamix Pharmaceuticals Ltd include Chief Scientific Officer Iain Stuart , director & CEO David Domzalski , and CLO and General Counsel Mutya Harsch .

Foamix Pharmaceuticals Ltd (FOMX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Foamix Pharmaceuticals Ltd (FOMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Foamix Pharmaceuticals Ltd (FOMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Foamix Pharmaceuticals Ltd (FOMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Foamix Pharmaceuticals Ltd Insider Transactions

No Available Data

What does Adamas Pharmaceuticals Inc do?

Who are the key executives at Adamas Pharmaceuticals Inc?

David Kroin is the 10 percent owner of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , Chief Financial Officer Christopher B Prentiss , and director & 10 percent owner William W. Ericson .

Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adamas Pharmaceuticals Inc Insider Transactions

No Available Data

What does Connecture Inc do?

Who are the key executives at Connecture Inc?

David Kroin is the 10 percent owner of Connecture Inc. Other key executives at Connecture Inc include 10 percent owner Francisco Partners Iv, L.p. , 10 percent owner Francisco Partners Iv-a, L.p. , and 10 percent owner Francisco Partners Gp Iv Management Ltd .

Connecture Inc (CNXR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Connecture Inc (CNXR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Connecture Inc (CNXR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Connecture Inc (CNXR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Connecture Inc Insider Transactions

No Available Data

What does InfuSystems Holdings Inc do?

Who are the key executives at InfuSystems Holdings Inc?

David Kroin is the 10 percent owner of InfuSystems Holdings Inc. Other key executives at InfuSystems Holdings Inc include EVP-Chief HR Officer Jerod Funke , Executive Vice President Richard Dilorio , and Executive VP and CFO Barry G Steele .

InfuSystems Holdings Inc (INFU) Insider Trades Summary

Over the past 18 months, David Kroin made no insider transaction in InfuSystems Holdings Inc (INFU). Other recent insider transactions involving InfuSystems Holdings Inc (INFU) include a net sale of 177,574 shares made by R. Rimmy Malhotra , a net sale of 69,743 shares made by Gregg Owen Lehman , and a net sale of 80,838 shares made by Christopher R. Sansone .

In summary, during the past 3 months, insiders sold 0 shares of InfuSystems Holdings Inc (INFU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 328,155 shares of InfuSystems Holdings Inc (INFU) were sold and 9,000 shares were bought by its insiders, resulting in a net sale of 319,155 shares.

InfuSystems Holdings Inc (INFU)'s detailed insider trading history can be found in Insider Trading Tracker table.

InfuSystems Holdings Inc Insider Transactions

No Available Data

What does Albireo Pharma Inc do?

Who are the key executives at Albireo Pharma Inc?

David Kroin is the director of Albireo Pharma Inc. Other key executives at Albireo Pharma Inc include director & President and CEO Cooper Ronald Harold Wilfred , Chief Human Resources Officer Michelle Graham , and CFO and Treasurer Harford Simon N.r. .

Albireo Pharma Inc (ALBO) Insider Trades Summary

Over the past 18 months, David Kroin made no insider transaction in Albireo Pharma Inc (ALBO). Other recent insider transactions involving Albireo Pharma Inc (ALBO) include a net sale of 2,814 shares made by Pamela Stephenson , a net sale of 3,285 shares made by Jan Mattsson , and a net sale of 1,878 shares made by Harford Simon N.r. .

In summary, during the past 3 months, insiders sold 0 shares of Albireo Pharma Inc (ALBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,134 shares of Albireo Pharma Inc (ALBO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 13,134 shares.

Albireo Pharma Inc (ALBO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Albireo Pharma Inc Insider Transactions

No Available Data

David Kroin Mailing Address

Above is the net worth, insider trading, and ownership report for David Kroin. You might contact David Kroin via mailing address: C/o Great Point Partners Llc, 165 Mason Street, 3rd Floor, Greenwich Ct 06830.

Discussions on David Kroin

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.